Agendia's Grant

Agendia raised a round of funding on December 16, 2015. Investors include Horizon 2020.

Agendia is a privately held, leading molecular diagnostics company that develops and markets FFPE-based genomic diagnostic products, which help support physicians with their complex treatment decision…

Articles about Agendia's Grant: